mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.19 |
0.2 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |